Adial Pharmaceuticals/$ADIL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Adial Pharmaceuticals
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Ticker
$ADIL
Sector
Primary listing
Employees
5
Headquarters
Website
ADIL Metrics
BasicAdvanced
$5.9m
-
-$8.22
1.46
-
Price and volume
Market cap
$5.9m
Beta
1.46
52-week high
$5.17
52-week low
$1.31
Average daily volume
884k
Financial strength
Current ratio
3.181
Quick ratio
3.036
Profitability
EBITDA (TTM)
-7.549
Management effectiveness
Return on assets (TTM)
-108.74%
Return on equity (TTM)
-265.94%
Valuation
Price to book
1.12
Price to tangible book (TTM)
1.12
Price to free cash flow (TTM)
-0.399
Free cash flow yield (TTM)
-250.68%
Free cash flow per share (TTM)
-6.894
Growth
Earnings per share change (TTM)
-78.89%
3-year earnings per share growth (CAGR)
-70.11%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs